Medical Technology

@xconomy.com 4 years ago

Drug Pricing: Innovation, Investment, and the Public Good

@xconomy.com 5 years ago

MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms

@xconomy.com 5 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@xconomy.com 5 years ago

Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More

@xconomy.com 5 years ago

Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More

@xconomy.com 5 years ago

Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections

@xconomy.com 5 years ago

Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines

@xconomy.com 6 years ago

Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs